JAGX Message Board Post 36286366 | Jaguar Health Inc.
home / stock / jagx / jagx message board
rainputnam
(investorshub)
Posted on: Mar/14/2024 10:14:42
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174035889
Yep, and formula(non GMO, gluten free) because right
News, Short Squeeze, Breakout and More Instantly...
-
New patents issued for core rare disease target indications for crofelemer Napo has approximately 200 patents issued and pending Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (...
-
Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024 Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific ...
-
Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis Cancer patients with diarr...